Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1

Drug Delivery

Volumn 22, Issue 3, 2015, Pages 276-285

  Baklaushev, Vladimir P ^a   Nukolova, Natalia N ^a,b   Khalansky, Alexander S ^c   Gurina, Olga I ^a   Yusubalieva, Gaukhar M ^a   Grinenko, Nadejhda Ph ^a   Gubskiy, Ilya L ^a   Melnikov, Pavel A ^a   Kardashova, Karina Sh ^a   Kabanov, Alexander V ^b,d   Chekhonin, Vladimir P ^a  

^a Serbsky National Research Center for Social and Forensic Psychiatry   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c RESEARCH INSTITUTE OF HUMAN MORPHOLOGY   (Russian Federation)

^d UNC Hamner Institute for Drug Safety Sciences   (United States)

Author keywords

Connexin 43; Glioblasoma multiforme; Monoclonal antibody; Nanogels; Targeted delivery

Indexed keywords

CISPLATIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BRAIN SPECIFIC ANION TRANSPORTER 1; MONOCLONAL ANTIBODY CONNEXIN 43; NANOGEL; NANOMATERIAL; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CONNEXIN 43; CONNEXIN 43 PROTEIN, RAT; DRUG CARRIER; GEL; ORGANIC CATION TRANSPORTER; SLCO1C1 PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CELL MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; ENDOSOME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL FILTRATION CHROMATOGRAPHY; GEL PERMEATION CHROMATOGRAPHY; GLIOMA; GLIOMA CELL; HYDROCEPHALUS; IC50; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYSOSOME; MOTOR ACTIVITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SURVIVAL; TUMOR VOLUME; WEIGHT REDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN NEOPLASMS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GEL; GLIOBLASTOMA; METABOLISM; PATHOLOGY; SURVIVAL ANALYSIS; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; CONNEXIN 43; DRUG CARRIERS; FEMALE; GELS; GLIOBLASTOMA; NANOSTRUCTURES; NEOPLASM TRANSPLANTATION; ORGANIC CATION TRANSPORT PROTEINS; RATS, WISTAR; SURVIVAL ANALYSIS;

EID: 84898880302     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.876460     Document Type: Article

References (19)

1. Baklaushev VP, Gurina OI, Yusubalieva GM, et al. (2009). Immunofluorescent analysis of connexin-43 using monoclonal antibodies to its extracellular domain. Bull Exp Biol Med 148: 725-30
2. Baklaushev VP, Kardashova KSh, Gurina OI, et al. (2012). Cloning and expression of brain-specific anion transporter BSAT1 and isolation of monoclonal antibodies to its extracellular fragment. Bull Exp Biol Med 152:734-8
3. Baklaushev VP, Yusubalieva GM, Tsitrin EB, et al. (2011). Visualization of connexin 43-positive cells of glioma and the periglioma zone by means of intravenously injected monoclonal antibodies. Drug Deliv 18:331-7
4. Bates DC, Sin WC, Aftab Q, Naus CC. (2007). Connexin43 enhances glioma invasion by a mechanism involving the carboxy terminus. Glia 55:1554-64
5. Chekhonin VP, Baklaushev VP, Yusubalieva GM, et al. (2012). Targeted Delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43. Nanomedicine 8:63-70
6. Hartmann JT, Lipp HP. (2003). Toxicity of platinum compounds. Expert Opin Pharmacother 4:889-901
7. Kabanov AV, Vinogradov SV. (2009). Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed Engl 48:5418-29
8. Li JY, Boado RJ, Pardridge WM. (2004). Blood-brain barrier genomics. J Cereb Blood Flow Metab 21:61-8
9. Nukolova NV, Oberoi HS, Cohen SM, et al. (2011a). Folate-Decorated nanogels for targeted therapy of ovarian cancer. Biomaterials 32: 5417-26
10. Nukolova NV, Yang Z, Kim JO, et al. (2011b). Polyelectrolyte nanogels Decorated with monoclonal antibody for targeted drug Delivery. React Funct Polym 71:315-23
11. Oberoi HS, Laquer FC, Marky LA, et al. (2011). Core cross-linked block ionomer micelles as pH-responsive carriers for cisdiamminedichloroplatinum( II). J Control Release 153:64-72
12. Oberoi HS, Nukolova NV, Laquer FC, et al. (2012). Cisplatin-loaDed core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice. Int J Nanomed 7:2557-71
13. Oliveira R, Christov C, Guillamo JS, et al. (2005). Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas. BMC Cell Biol 6:7
14. Peer D, Karp JM, Hong S, et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751-60
15. Prochnow N, Dermietzel R. (2008). Connexons and cell adhesion: a romantic phase. Histochem Cell Biol 130:71-7
16. Steiniger SC, Kreuter J, Khalansky AS, et al. (2004). Chemotherapy of glioblastoma in rats using doxorubicin-loaDed nanoparticles. Int J Cancer 109:759-67
17. Sugiyama D, Kusuhara H, Taniguchi H, et al. (2003). Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. J Biol Chem 278):43489-95
18. Wohlfart S, Khalansky AS, Bernreuther C, et al. (2011). Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles. Int J Pharm 415:244-51
19. Yusubalieva GM, Baklaushev VP, Gurina OI, et al. (2012). Antitumor effects of monoclonal antibodies to connexin 43 extracellular fragment in induced low-differentiated glioma. Bull Exp Biol Med 153:163-9